rhBNP in Type 3 Pulmonary Hypertension
NCT05716984
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
72
Enrollment
OTHER
Sponsor class
Conditions
Group 3 Pulmonary Hypertension
Interventions
DRUG:
recombinant human brain natriuretic peptide
DRUG:
Placebo
Sponsor
Shengjing Hospital